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The intracellular signaling molecule, cyclic-di-GMP (c-di-GMP), has been shown to influence bacterial
behaviors, including motility and biofilm formation. We report the identification and characterization of
PA4367, a gene involved in regulating surface-associated behaviors in Pseudomonas aeruginosa. The PA4367
gene encodes a protein with an EAL domain, associated with c-di-GMP phosphodiesterase activity, as well as
a GGDEF domain, which is associated with a c-di-GMP-synthesizing diguanylate cyclase activity. Deletion of
the PA4367 gene results in a severe defect in swarming motility and a hyperbiofilm phenotype; thus, we
designate this gene bifA, for biofilm formation. We show that BifA localizes to the inner membrane and, in
biochemical studies, that purified BifA protein exhibits phosphodiesterase activity in vitro but no detectable
diguanylate cyclase activity. Furthermore, mutational analyses of the conserved EAL and GGDEF residues of
BifA suggest that both domains are important for the observed phosphodiesterase activity. Consistent with
these data, the bifA mutant exhibits increased cellular pools of c-di-GMP relative to the wild type and
increased synthesis of a polysaccharide produced by the pel locus. This increased polysaccharide production is
required for the enhanced biofilm formed by the bifA mutant but does not contribute to the observed
swarming defect. The bifA mutation also results in decreased flagellar reversals. Based on epistasis studies
with the previously described sadB gene, we propose that BifA functions upstream of SadB in the control of
biofilm formation and swarming.
The gram-negative bacterium Pseudomonas aeruginosa is an
important model organism for the study of bacterial surface
interactions, including biofilm formation and surface-mediated
twitching and swarming motilities. However, the precise mo-
lecular mechanisms required for transition from a planktonic
mode of existence to that of a surface-associated lifestyle are
only beginning to come to light.
In the case of biofilm formation, microscopic studies, as well
as genetic analyses, have shown that the initial surface attach-
ment phase by P. aeruginosa proceeds in two distinct steps (8,
20). In the first step, known as reversible attachment, cells are
loosely attached via a single cell pole and may readily detach
and return to the planktonic phase. In the second step, cells
that are tethered by a pole become attached via the long axis
of the cell body. Such cells, deemed irreversibly attached, are
more firmly attached to the surface. Genetic studies of initial
attachment have led to the identification of SadB, a key compo-
nent required for this transition from reversible to irreversible
attachment in P. aeruginosa (8).
The ability to form a robust biofilm also requires the pro-
duction of an exopolysaccharide (EPS) component of the bio-
film matrix. Recent studies have identified genetic loci that are
important for synthesis of an EPS component of biofilm matrix
in several P. aeruginosa strains. In PA14, the pel genes are
required for the production of a glucose-rich EPS (15, 16). In
addition to the pel locus, the PAO1 strain also harbors a locus
not found in PA14, the psl gene cluster, shown to produce a
mannose-rich matrix (16, 23, 31). While these and other stud-
ies indicate that EPS production contributes to the overall
structure of the mature biofilm (14), more recent data suggest
that the pel and psl loci also play roles in initial attachment in
strains PAK (54) and PAO1 (29), respectively.
Whereas biofilm formation is a surface-associated sessile
behavior, swarming is a surface-associated motile behavior. In
P. aeruginosa strain PA14, swarming motility is the flagellum-
propelled movement of bacteria across surfaces, aided by the
production of rhamnolipids as a surface-wetting agent (26, 53).
Given that biofilm formation and swarming motility are both
surface-associated behaviors, it seems plausible that bacteria
are able to transition from one behavior to another as dictated
by changing surface conditions. One potential explanation for
how cells might transition from one surface behavior to an-
other is that these surface behaviors are coregulated. Caiazza
et al. have provided evidence to establish that SadB coregu-
lates both biofilm formation and swarming motility and is able
to inversely control these two surface behaviors (7). Based on
this evidence, these authors put forth a model wherein SadB
controls biofilm formation and swarming motility by inversely
regulating both the rate of flagellar reversals and the produc-
tion of the pel-derived polysaccharide.
The inverse regulation of biofilm formation and swarming
motility by SadB is reminiscent of the regulation of sessile and
* Corresponding author. Mailing address: Department of Microbi-
ology and Immunology, Dartmouth Medical School, Rm. 505, Vail
Building, North College St., Hanover, NH 03755. Phone: (603) 650-
1248. Fax: (603) 650-1245. E-mail: georgeo@dartmouth.edu.
† Supplemental material for this article may be found at http://jb
.asm.org/.
 Published ahead of print on 22 June 2007.
8165
motile behaviors via a bacterial regulatory system involving the
signaling molecule cyclic-di-GMP (c-di-GMP) (13, 24, 42, 43).
In a growing number of bacterial systems, it has been shown
that intracellular levels of this signaling molecule influence a
myriad of bacterial behaviors, with the common theme being
that the accumulation of c-di-GMP promotes sessile behaviors,
such as biofilm formation, while the breakdown of c-di-GMP
and subsequent decrease in cellular levels of this signal favors
motile behaviors, such as swarming motility (5, 6, 19, 25, 40,
50).
Presumably, the steady-state level of c-di-GMP in the cell is
controlled by the relative rates of synthesis and degradation of
this molecule. The synthesis of c-di-GMP from two molecules
of GTP is catalyzed by diguanylate cyclases (DGCs), enzymes
characterized by the presence of a GGDEF domain (19, 40, 45,
51), whereas the breakdown of c-di-GMP is catalyzed by phos-
phodiesterases (PDEs), enzymes noted for possessing an EAL
or an HD-GYP domain (5, 11, 44, 47, 51, 52).
In a companion manuscript, Merritt et al. establish that
SadC, a novel GGDEF-containing protein that modulates cel-
lular pools of c-di-GMP in P. aeruginosa PA14, functions ge-
netically upstream of SadB in inversely controlling both biofilm
formation and swarming motility (32). We postulated that a
PDE should also be involved in degrading the c-di-GMP pro-
duced by SadC. Here we describe the identification of BifA, a
c-di-GMP PDE that participates with SadC in the inverse reg-
ulation of biofilm formation and swarming motility and does so
in a SadB-dependent manner.
MATERIALS AND METHODS
Strains and media. Strains, plasmids and primers used in the present study are
listed in Table 1. P. aeruginosa PA14 and Escherichia coli DH5 and JM109 were
routinely cultured on lysogeny broth (LB) medium (4), solidified with 1.5% agar
where appropriate. For P. aeruginosa, gentamicin (Gm) was used from 50 to 100
g/ml. For E. coli, Gm was used at 10 g/ml and ampicillin was used at 150
g/ml. M63 minimal salts medium (39) supplemented with MgSO4 (1 mM),
glucose (0.2%), and Casamino Acids (CAA; 0.5%) was used for all P. aeruginosa
phenotypic assays unless otherwise noted. For arabinose-inducible plasmids,
arabinose was added to cultures at a 0.5% final concentration.
Saccharomyces cerevisiae strain InvSc1 (Invitrogen) was used for in vivo ho-
mologous recombination for plasmid constructions and was grown with yeast
extract-peptone-dextrose (1% Bacto yeast extract, 2% Bacto peptone, and 2%
dextrose) (48). Selections with InvSc1 were performed by using synthetic defined
agar-uracil (Qbiogene, 4813-065) (48).
Construction of mutant strains. A deletion of the bifA gene was constructed
by first amplifying an 1-kb PCR fragment upstream of bifA using the primer
pair KO-2 and KO-3 and an 1-kb PCR fragment downstream of bifA using
primers KO-1 and KO-4 (primer sequences are listed in Table 1). PCR for strain
constructions was performed with Phusion polymerase (New England Biolabs,
Beverly, MA) according to the manufacturer’s instructions, whereas PCR for
screening and confirmation of mutations was performed with Taq polymerase
(New England Biolabs) under standard conditions. Primers KO-1 and KO-2 are
reverse complements of one another, with the underlined sequence located at
the 5 end of bifA and the italicized sequence located at the 3 end of bifA (see
Table 1). Primers KO-3 and KO-4 contain 35 bp of homology to the vector
pMQ80 (Table 1, lowercase sequence). The two PCR fragments were cloned
together into pMQ80 (linearized by SacI digestion) by in vivo homologous
recombination in yeast as reported (48), resulting in a construct carrying a
deletion of bifA from nucleotides 1 to 1941 of the 2,064-bp full-length gene
surrounded by1 kb of upstream and downstream flanking DNA. Plasmids were
recovered from yeast as described, transformed via electroporation into E. coli
DH5, and screened by colony PCR, followed by plasmid isolation and sequenc-
ing to confirm the deletion. The bifA deletion construct was then reamplified by
using primers KO-3/HindIII and KO-4/XbaI, digested with HindIII/XbaI, and
cloned into the suicide vector pEX18-Gm (22). The resulting construct (pEX-
bifA) was transformed into P. aeruginosa by electroporation as described pre-
viously (10). Integrants were isolated on Gm and subjected to sucrose selection,
and the resolved integrants were confirmed by PCR and sequencing. The pEX-
bifA construct was used in the same manner to generate a deletion of bifA in the
sadB and sadC mutant backgrounds, resulting in the double bifA sadB::Tn5 and
bifA sadC mutants.
The pelA mutation was generated by a single-crossover (SCO) insertion using
the pMQ89 suicide vector (48). The pMQ89-pelA-SCO construct consisted of a
620-bp 5 fragment (nucleotides 52 to 672) of the pelA gene amplified using
primers containing in-frame translational stop codons (pelA-HindIII and pelA-
Xba) and cloned into HindIII/XbaI-digested pMQ89. This construct was trans-
formed into P. aeruginosa, transformants were isolated, and insertions were
confirmed by PCR using the vector primer pF-t1t2 and pelA-3 end primer. The
pMQ89-pelA-SCO construct was also introduced into the bifA mutant to gen-
erate the bifA pelA double mutant.
bifA complementation constructs. (i) Multicopy constructs for arabinose-in-
ducible expression of the bifA gene. An arabinose-inducible, N-terminal His6-
tagged copy of bifA was generated by homologous recombination in yeast, using
the vector pMQ80. Two overlapping PCR products spanning bifA and including
the His6 tag were generated by using the primer pairs bifA-5Kpn/N-His-R and
bifA-3HIII/N-His-F. These PCR products were joined with pMQ80 (linearized
with SacI) by homologous recombination as described previously (48) to gener-
ate the full-length His-tagged bifA-containing plasmid designated pMQ80-His-
bifA.
N-terminal His6-tagged mutant versions of bifA were also generated by ho-
mologous recombination in pMQ80. Overlapping PCR fragments with mutations
converting the GGDQF amino acid residues to alanine residues (GGDQF to
AAAAA) were generated by using primer GG/Ala-F with bifA-3HIII and
primer GG/Ala-R with N-His-F (Table 1, the mutated residues are underlined).
These fragments were combined with the bifA-5Kpn/N-His-Rev fragment to
generate the full-length His-tagged bifA-AAAAA-containing plasmid designated
pMQ80-His-bifA-AAAAA.
Overlapping PCR fragments for mutating the conserved glutamic acid residue
of the EAL domain (EAL to AAL) were generated using primers AAL-For with
bifA-3HIII and AAL-Rev with N-His-F. These fragments were combined with
the bifA-5Kpn/N-His-Rev fragment to generate the full-length His-tagged bifA-
AAL construct designated pMQ80-His-bifA-AAL.
(ii) Tn7 constructs for single-copy chromosomal insertion of bifA and expres-
sion under the control of its native promoter. The His-tagged bifA insert in the
pMQ80-His-bifA construct was excised by using KpnI and HindIII and cloned
into the pUC18-mini-Tn7T-Gm vector (9), yielding the plasmid pTn7-His-bifA.
Transposition of the Tn7 element was performed by coelectroporation of the
pUC18-mini-Tn7T-Gm vector (or pTn7-His-bifA) with the helper plasmid
pUX-BF13 as described previously (9). Transposon insertions of the Tn7 alone
or Tn7-His-bifA were generated in the wild type (WT) (yielding strains
SMC3374 and SMC3403, respectively) and in the bifA mutant (yielding strains
SMC3369 and SMC3401, respectively). Transposon insertions were confirmed by
PCR using the primers glmS-up and bifA-up.
Biofilm formation assays. Biofilm formation in 96-well microtiter plates was
assayed essentially as previously described (8, 37). For complementation of bifA
biofilm formation using pMQ80 constructs, arabinose was added to a 0.5% final
concentration.
Microscopy. (i) ALI assay. Air-liquid interface (ALI) analysis was performed
as described previously (8) except that bacteria attached to the surface were
visualized after 6 h.
(ii) Measurement of initial attachment. Strains were grown and prepared for
measurements of initial attachment as described previously (7), except that
cultures were diluted 1:200, and cells were incubated for 30 min prior to enu-
meration. Surface-attached cells were counted over eight fields of view per strain,
and the data are presented as the average number of cells per field.
(iii) Quantification of reversible and irreversible attachment. The transition
from reversible to irreversible attachment was monitored as described previously
(8) except that cultures were diluted 1:200. Phase-contrast time-lapse images
were captured at 1 frame per s for 60 s and converted to QuickTime movies for
analysis. Irreversibly attached cells were scored as cells that did not move during
the 1-min interval and were attached by the long axis of the cell. Reversibly
attached cells were those that moved during the interval and were attached by a
cell pole (8).
(iv) Measurement of swim reversal frequency. Cells were grown and prepared
for swim reversal frequency analysis as described previously (7), except that
cultures were diluted 1:200 in M63 medium supplemented with glucose in the
presence of 15% Ficoll (high-viscosity/swarming conditions) (53). Time-lapse
images were captured every 0.3 s for 60 s, and images were converted to Quick-
Time movies for subsequent analysis. Approximately 15 cells per movie were
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TABLE 1. Strains, plasmids, and primers
Strain, plasmid, or primer Relevant genotype or sequence Source orreference
P. aeruginosa PA14 strains
SMC232 WT 41
12-3H6 (bifA)::Tn 28
SMC3351 bifA This study
SMC3417 bifA sadC This study
SMC3430 bifA sadB::Tn5 This study
SMC3051 pelA::pMQ89 This study
SMC3381 bifA pelA::pMQ89 This study
SMC3374 WT::Tn7 This study
SMC3403 WT::Tn7-His-bifA This study
SMC3369 bifA::Tn7 This study
SMC3401 bifA::Tn7-His-bifA This study
Plasmids
pEX-18-Gm Knockout vector 22
pEX-bifA bifA deletion mutant construct This study
pMQ89 Suicide cloning vector 48
pMQ89-pelA-SCO pelA SCO knockout vector This study
pMQ80 Cloning vector with arabinose-inducible promoter 48
pMQ80-His-bifA Expresses WT His-tagged BifA under the control of an arabinose-inducible
promoter
This study
pMQ80-His-bifA-AAAAA Expresses His-tagged BifA-AAAAA under the control of an arabinose-inducible
promoter
This study
pMQ80-His-bifA-AAL Expresses His-tagged BifA-AAL under the control of an arabinose-inducible
promoter
This study
pUX-BF13 Helper plasmid for Tn7 transposition 9
pUC18-mini-Tn7T-Gm Single-copy Tn7 insertion plasmid 9
pTn7-His-bifA Single-copy Tn7 insertion plasmid containing the His-tagged bifA gene with its
endogenous promoter region
This study
pQE-30 Expression vector Invitrogen, Inc.
pQE-30-bifA Expresses His-BifA under an IPTG-inducible promoter This study
pQE-30-bifA-AAAAA Expresses His-BifA-AAAAA under an IPTG-inducible promoter This study
pQE-30-bifA-AAL Expresses His-BifA-AAL under an IPTG-inducible promoter This study
Primers
KO-1 CGACGAACAAGGAAGGCCCCGAGCAGGAGGCGTACATCATC
KO-2 GATGATGTACGCCTCCTGCTCGGGGCCTTCCTTGTTCGTCG
KO-3 tttctccatacccgtttttttgggctagcgaattcCTTGCAGAAGCCCGTCGCAG
KO-4 tcctttactcatatgtatatctccttccccgggtaccCCCGTGTCGCTGGCTTCAAG
KO-3/HindIII GGCGAAGCTTCTTGCAGAAGCCCGTCGCAG
KO-4/XbaI GGCGTCTAGACCCGTGTCGCTGGCTTCAAG
pelA-HindIII GGCGAAGCTTTGAAACATCCTTCGACCCATCGAG
pelA-XbaI GGCGTCTAGATCACCAACCGGCATGGATCGACTC
pF-t1t2 CAGACCGCTTCTGCGTTCTG
pelA-3end ATCGGCAACTCGAACGTCCACAG
bifA-5Kpn tttctccatacccgtttttttgggctagcgaattcaagcttTGGAACCTGGTCAACTGGGAC
N-His-F ACGAACAAGGAAGGCCCCTTGCACCACCACCATCACCACAAACTGGA
CTCCCGACACAG
bifA-3HIII tcctttactcatatgtatatctccttccccgggtaccGAGGACGATCTCGCCGTGCGAC
N-His-R GTTTGTGGTGATGGTGGTGGTGCAAGGGGCCTTCCTTGTTCGTC
glmS-up CTCAAGTCGAACCTGCAGGAAGTC
bifA-up GCGAGACCACGGAGAAACTGC
GG/Ala-F CGGTTCGCTGGCGCGCCTGGCCGCCGCGGCCGCCGCCCTGGTCCAGG
CCGAC
GG/Ala-R GTCGGCCTGGACCAGGGCGGCGGCCGCGGCGGCCAGGCGCGCCAGC
GAACCG
AAL-For CACCGCGTGGTCGGCGTCGCCGCACTGCTGCGCTGGCAACATC
AAL-Rev GATGTTGCCAGCGCAGCAGTGCGGCGACGCCGACCACGCGGTG
rplU1 CGCAGTGATTGTTACCGGTG
rplU2 CAACCGCAATGGGCGCTATTGC
pelA-F TCAATCGCGGTTTCGAAGTGCTGC
pelA-R ATCCAGGTGACCCTTCAGCCAATC
pelG-F TATTGCTGGCGACCCTGTTCGATG
pelG-R ATGAAACGCAGCAGGTAGGCACAG
EALHis-SacI GGCGGAGCTCTTGAAACTGGACTCCCGACACAG
EALHis-HindIII GGCGAAGCTTTCAGGGCCGTTCGCTGCTGGTGG
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counted in nine movies (135 cells total) for each strain to determine the
reversal frequencies, which are expressed as the number of reversals per cell.
CR binding assays. Congo red (CR) binding assays were performed as re-
ported (7, 15, 16). Bacteria from LB-grown overnight cultures were spotted (2
l) onto the plates and grown for 24 h at 37°C, followed by 48 h at room
temperature.
qRT-PCR. The WT and the bifA mutant strain were grown under the con-
ditions described for the CR assays, but without the dyes added (see above).
Colonies were harvested and resuspended in M63 medium and normalized to an
optical density at 600 nm (OD600) of 0.4. Cells were spun briefly at 16,000  g to
pellet, the supernatants were removed, and the pellets were flash-frozen in a dry
ice-ethanol bath for 15 min. RNA was isolated, cDNA was prepared, and quan-
titative reverse transcription-PCR (qRT-PCR) was performed as reported (27).
Expression levels were quantified in picograms of input cDNA using a standard
curve method for absolute quantification, and these values were normalized to
rplU expression. The primers used are listed in Table 1.
Motility assays. Swim (0.3% agar) and twitch (1.5% agar) motility plates
consisted of M63 medium supplemented with glucose, MgSO4, and CAA. Swim
and twitch assays were carried out as reported previously (38, 55). The diameters
of the swim zones were measured in millimeters and averaged over four replicate
platings for each strain repeated twice. The diameters of twitch zones were
measured in millimeters, and the data were averaged over three replicate plat-
ings repeated twice.
Swarm (0.5% agar) motility plates consisted of M8 minimal medium (26)
supplemented with glucose, MgSO4, and CAA. Swarm plate preparation, inoc-
ulation, and incubation were performed as previously reported (53). Diameters
of swarm zones were measured in millimeters for each strain, and the data are
presented as averages over triplicate platings. To detect rhamnolipid production
in the bifA mutant, rhamnolipid assays were performed as reported earlier (49)
using the same base medium as for the swarming assays but with 1.5% agar.
Assessing the stability of the WT and mutant BifA proteins for complemen-
tation of the bifA mutant. Strains carrying either pMQ80 alone, pMQ80-His-
bifA, pMQ80-His-bifA-AAL. or pMQ80-His-bifA-AAAAA were grown under
the same conditions used for the biofilm complementation assays. LB-grown
overnight cultures were normalized by the OD600; diluted (1:50) into M63 me-
dium supplemented with glucose, MgSO4, CAA, and arabinose; and grown
statically for 6 h at 37°C. Cells (20 ml) were harvested by centrifugation at 4,400 
g and resuspended in 1 sodium dodecyl sulfate (SDS) gel loading buffer with
100 mM dithiothreitol. Samples were boiled for 10 min and resolved by SDS-
polyacrylamide gel electrophoresis (PAGE) in a 7.5% polyacrylamide gel (Bio-
Rad, Hercules, CA). Proteins were transferred to a nitrocellulose membrane and
probed with an anti-penta-His antibody (QIAGEN, Valencia, CA). Western
blots were developed with the Western Lightning ECL detection kit (Perkin-
Elmer, Boston, MA) according to the instructions of the manufacturer.
Cellular localization of BifA. Cell fractionations were carried out as previously
reported (34) with modifications. LB-grown overnight cultures were diluted
(1:100) into LB (250 ml) containing Gm (25 g/ml) and arabinose (0.5%) and
grown for 4 h (OD600  0.9) at 37°C with shaking. Bacterial cells were har-
vested by centrifugation at 5,520  g for 15 min and washed once in phosphate-
buffered saline. Cells were collected by centrifugation at 4,400  g, the super-
natants were removed, and the cell pellets were frozen at 	80°C. Cell pellets
were resuspended in buffer A (200 mM Tris-HCl [pH 7.5], 20 mM EDTA [pH
8.0], 1 Complete protease inhibitors [Roche Diagnostics Corp., Indianapolis,
IN]) and lysed in a French pressure cell. Samples were centrifuged at 9,300  g
for 10 min at 4°C to remove unbroken cells, and supernatants were collected as
whole-cell lysates. To separate the cytoplasmic fraction from the total membrane
(TM) fraction, whole-cell lysates were centrifuged at 100,000  g for 1 h at 4°C.
The soluble fraction was collected as the cytoplasmic fraction. Membrane pellets
were resuspended in buffer B (20 mM Tris-HCl [pH 7.6]) to yield the TM
fraction. The TM was further fractionated by using Sarkosyl solubilization of the
inner membrane. An equal volume of 4% Sarkosyl in buffer B was added to the
TM fraction, and samples were incubated at room temperature for 20 min with
shaking. Samples were then centrifuged at 100,000 g for 1 h at 4°C. The soluble
portion was collected as the inner-membrane fraction. Pellets were resuspended
in buffer B to yield the outer-membrane fraction. Aliquots of all fractions were
stored in 10% glycerol and protease inhibitors at 	80°C.
For Western blots of cellular fractions, samples from each fraction were
diluted to the same concentration (0.2 mg/ml) and 1 g of total protein from
each fraction was mixed with SDS loading buffer containing dithiothreitol (100
mM). Concentrations of total protein in each fraction were determined by using
a Bio-Rad DC protein assay kit according to the manufacturer’s instructions.
Samples were resolved by SDS-PAGE using either 7.5% (BifA and SecY) or a 4
to 15% gradient (OprF) polyacrylamide gels (Bio-Rad). Proteins were trans-
ferred to a nitrocellulose membrane and probed with one of three antibodies: (i)
anti-penta-His antibody (QIAGEN) to detect His-tagged BifA, (ii) SecY antisera
(21) to detect the inner membrane protein SecY (1), and (iii) antisera to detect
the outer-membrane protein OprF (3, 18, 30). Western blots were developed as
described above.
Expression and purification of His-tagged BifA. To express His-tagged BifA
protein for purification in E. coli, the bifA gene was amplified by PCR using
primers EALHis-SacI and EALHis-HindIII and cloned into the SacI/HindIII-
digested pQE-30 vector (Invitrogen) harboring an N-terminal His6 tag. The bifA
mutants (GGDQF to AAAAA and EAL to AAL) were generated by PCR
amplification with the primers used above (EALHis-SacI and EALHis-HindIII)
using the mutant bifA templates generated for the complementation constructs
in pMQ80 (see above) followed by cloning into pQE-30.
E. coli JM109 strains carrying either pQE-30 alone, pQE-30-bifA, pQE-30-
bifA-AAL, or pQE-30-bifA-AAAAA constructs were grown overnight in LB-
ampicillin, diluted 1:100, and grown for 4 h at 37°C. Expression of His-tagged
BifA protein was induced with addition of 0.4 mM IPTG (isopropyl-
-D-thio-
galactopyranoside), followed by incubation at 12°C overnight. Cultures were
harvested by centrifugation at 5,520  g for 10 min and resuspended in wash
buffer (20 mM imidazole, 20 mM Na2HPO4, 20 mM NaH2PO4, 500 mM NaCl,
1% Triton X-100, 4 mM MgCl2, and 10 mg of DNase I [Roche Diagnostics Corp.,
Indianapolis, IN]/ml). Cells were lysed in a French pressure cell, and the extract
was clarified by centrifugation at 5,520  g for 15 min. The soluble fraction was
filtered through a 0.22-m-pore-size filter. From this filtrate (crude extract),
His-tagged BifA was purified by using a His-Trapp-FF NiSO4 column (GE
Healthcare, Piscataway, NJ) and collected from the column in elution buffer (150
mM imidazole, 20 mM Na2HPO4, 20 mM NaH2PO4, 500 mM NaCl) by using a
fraction collector (Bio-Rad). Eluate fractions containing BifA protein, as deter-
mined by SDS-PAGE separation and Coomassie blue staining, were treated with
protease inhibitors (Roche Diagnostics), pooled, and dialyzed for 3 h using a
Slide-A-Lyzer dialysis cassette (Pierce Biotechnology, Inc., Rockford, IL) against
the dialysis buffer (75 mM Tris [pH 9.3], 30% glycerol, 200 mM NaCl, 10 mM
MgCl2 25 mM KCl). Dialyzed samples were concentrated by using an Amicon
Ultracel column (30,000 molecular weight cutoff) (Millipore, Billerica, MA).
Protein concentrations were determined by using the RC DC protein assay kit.
Protein purity was assessed by SDS-PAGE separation and Coomassie blue stain-
ing or Western blot analysis with a penta-His antibody (QIAGEN).
In vitro PDE activity assays. (i) bis-pNPP cleavage assays. PDE activity of
BifA was first assessed using the synthetic substrate, bis(p-nitrophenyl) phos-
phate (bis-pNPP), as previously described (5). Briefly, 20 l of purified BifA (0.4
mg/ml) was incubated with bis-pNPP (5 mM) in buffer (5 mM MgCl2, 50 mM
Tris-HCl [pH 9.3], 50 mM NaCl) for 60 to 90 min. The release of p-nitrophenol
was quantified at OD410 in a spectrophotometer (Molecular Devices, Sunnyvale,
CA). A dose-response curve was generated by assaying twofold serial dilutions of
purified BifA in the reaction for 20 min. The PDE activity of crude extracts (20
l of 1 mg of total protein/ml) containing WT BifA, BifA-AAL, BifA-AAAAA,
or vector alone was also assayed as described above.
(ii) c-di-GMP cleavage assays. Radiolabeled c-di-GMP substrate was synthe-
sized by using purified PleD enzyme and [32P]GTP and processed as previously
reported (33, 52). This substrate was then used in PDE activity assays which were
performed as described previously (11, 33) using crude extracts. Reactions were
incubated at room temperature (for 24 h) and terminated by the addition of 10
l of 0.5 M EDTA (pH 8.0). Reaction products were separated by thin-layer
chromatography (TLC) as described previously (33). TLC plates were exposed
overnight on phosphorimaging screens (GE Healthcare) and analyzed on a
Storm 860 (Molecular Devices).
In vivo quantification of c-di-GMP. Whole-cell [32P]orthophosphate labeling,
acid extraction, and two-dimensional TLC analysis of c-di-GMP for quantifica-
tion were performed as reported elsewhere (19, 33). Quantification of labeled
c-di-GMP was determined by using ImageQuant software v5.1 (Molecular De-
vices). The percentage of label incorporated into c-di-GMP was normalized to
total 32P labeling and is expressed as the percent c-di-GMP.
RESULTS
Isolation and initial characterization of the PA4367::Tn mu-
tant. The PA4367::Tn mutant was initially isolated in a screen
to identify novel genes that function together with the sadC
gene in regulating biofilm formation in P. aeruginosa. The role
of the sadC gene in biofilm formation is described in a com-
panion manuscript (32). Merritt et al. report that sadC mutants
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exhibit severely reduced biofilm formation and also show re-
duced CR binding, indicating a decrease in polysaccharide
production. The sadC mutant also shows enhanced swarming
motility. The sadC gene encodes a protein with a GGDEF
domain, which is associated with a c-di-GMP-synthesizing
DGC activity. The phenotypes of sadC mutants are consistent
with decreased levels of the signaling molecule, c-di-GMP—a
decrease in c-di-GMP pools tends to promote a more motile
lifestyle over a sessile mode of existence (13, 24, 42, 50).
Based on the studies of sadC described above, we predicted
that genes functioning together with sadC in regulating biofilm
formation would likely include those that impact the synthesis
and/or stability of c-di-GMP. For example, proteins with EAL
or HD-GYP domains are associated with c-di-GMP-degrading
PDE activity (11, 17, 44, 47). Mutations in a c-di-GMP PDE
would be expected to elevate intracellular levels of c-di-GMP
and potentially lead to hyperbiofilm formation, increased CR
binding, and decreased swarming motility (phenotypes oppo-
site of those observed for the sadC mutant). Thus, we incor-
porated all three phenotypic criteria in a screen for such mu-
tants.
Recently, Ausubel and coworkers reported the generation of
a transposon insertion mutant library of P. aeruginosa strain
PA14 (28). This PA14NR library is a nonredundant collection
of 5,459 transposon mutants representing insertions in a ma-
jority of nonessential genes in P. aeruginosa PA14. To validate
the utility of the PA14NR library, Liberati et al. screened for
mutants with altered biofilm formation under the same mini-
mal medium growth conditions used to isolate the sadC mutant
(28). Approximately 420 mutants were isolated as biofilm de-
fective, which included both reduced and enhanced biofilm
formers relative to the WT (see Table S1 in the supplemental
material). The resulting list of biofilm-defective mutants in-
cludes a number of genes previously shown to be important for
biofilm formation, including mutations in genes required for
flagellum and pilus synthesis, as well as the crc and sadB genes
(8, 36, 37). The sadC gene (PA4332) was represented by a
mutation in the sadC operon. A second GGDEF-containing
gene, the previously characterized wspR gene (PA3702), was
also identified. The wspR gene has been shown to be required
for autoaggregation and biofilm formation in LB medium by P.
aeruginosa strain PAO1 (12, 19). In addition to known biofilm
factors, new genes with as-yet-uncharacterized roles in biofilm
formation were also isolated. Together, these results represent
the desired outcome for such a screen and, as such, confirm the
utility of the PA14NR mutant library.
To screen for genes that might function in the same pathway
as sadC, this subset of 420 transposon mutants with biofilm
phenotypes was subjected to a second round of biofilm assays,
in parallel with CR binding and swarm assays, to identify those
mutants that formed hyper-biofilms, bound increased levels of
CR, and showed decreased swarming motility. Of the 420 bio-
film-altered mutants screened, we identified 55 mutants that
were both hyper-biofilm formers and hyper-CR binders. Of
those 55 mutants, 34 mutants were also completely defective
for swarming motility (see Table S2 in the supplemental ma-
terial).
From this list of 34 mutants, we chose to focus on the 12-3H6
mutant carrying a transposon insertion in the PA4367 open
reading frame. The PA4367 gene is the only gene with an EAL
or HD-GYP motif represented in this subset of mutants. While
there are two other genes encoding EAL motifs represented in
the larger collection of 420 biofilm-defective mutants, neither
of these mutants satisfies all three of the phenotypic criteria
used in the second round of screening. The PA4367 gene also
contains a GGDEF-like motif, with the sequence GGDQF in
the core motif. Therefore, the PA4367::Tn mutant satisfied our
criteria of having biofilm, CR, and swarming phenotypes op-
posite of the sadC mutant, and motifs consistent with a role in
c-di-GMP metabolism, indicating that PA4367 might antago-
nize the action of sadC with respect to these behaviors. Based
on the biofilm phenotype of PA4367::Tn mutant, we propose
to designate this gene bifA for biofilm formation.
The bifA gene negatively impacts biofilm formation at early
stages. To confirm and further analyze the biofilm phenotypes
of the bifA::Tn mutant, we constructed a deletion mutation
that removes nucleotides 1 to 1941 of the 2,046-nucleotide
coding region of the bifA gene (See Materials and Methods for
details). We then tested the bifA deletion mutant in a 96-well
microtiter assay compared to the bifA::Tn mutant. Quantifica-
tion of the crystal violet-stained biofilms for this analysis is
shown in Fig. 1A. After growth for 6 h, the bifA::Tn and the
bifA mutants both exhibited greatly enhanced biofilm forma-
tion (5.5-fold) over that of the WT. Both mutants grow at a
rate indistinguishable from that of the WT (data not shown)
under these same medium conditions, demonstrating that en-
hanced biofilm formation observed in the mutants is not due to
increased growth rate.
To show that the hyperbiofilm formed by the bifA mutant
is specifically due to mutation of the bifA gene, we generated a
complementation construct (pTn7-His-bifA) to express a His-
tagged version of the bifA gene from its native promoter in
single copy on the chromosome via Tn7 insertion at a previ-
ously characterized chromosomal site (9). The Tn7 element
alone had no effect on biofilm formation in the WT or the
bifA mutant strain (WT::Tn7 and bifA::Tn7) (Fig. 1A), in-
dicating that neither the Tn7 element itself nor its physical
insertion into the chromosome leads to any impact on biofilm
formation. The Tn7-His-bifA element resulted in a 50%
decrease in biofilm formed by the WT (WT::Tn7-His-bifA)
relative to the WT::Tn7 control strain. However, the Tn7-His-
bifA complementation construct in the bifA mutant
(bifA::Tn7-His-bifA) reduced biofilm formation7-fold rel-
ative to the bifA::Tn7 control strain and resulted in a level of
biofilm formation similar to that seen in the WT::Tn7 control
strain. Thus, single-copy expression of the His-tagged BifA,
expressed under its own promoter, is capable of restoring bio-
film formation to WT levels in the bifA mutant. These results
support the conclusion that mutation of the bifA gene is solely
responsible for the observed hyperbiofilm phenotype of the
bifA mutant.
Biofilms formed by the WT, the bifA mutant, and the
complemented strains were also examined microscopically
(Fig. 1B) using the ALI assay (see Materials and Methods)
under the same growth conditions used in Fig. 1A. The data
show that cells of the WT alone or the WT::Tn7 control form
distinct microcolonies of surface-attached bacteria surrounded
by open (noncolonized) surface area at 6 h. Cells of the bifA
mutant alone or the bifA::Tn7 control form much more
densely packed microcolonies with greatly reduced noncolo-
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nized surface area compared to the WT cells. In contrast, cells
of the bifA mutant carrying the Tn7-His-bifA insertion are
only sparsely attached and form far fewer microcolonies. WT
cells carrying the Tn7-His-bifA insertion show slightly re-
duced attachment and microcolony formation compared to the
WT or the WT::Tn7 control. These data are entirely consistent
with the observations made with the 96-well plate assay (Fig.
1A).
The direct microscopic observations of biofilm formation
described above indicate that there are more bifA cells than
WT cells attached to the surface after 6 h of biofilm formation.
In order to assess whether this difference in attachment was
apparent at an earlier time point, we repeated these assays, but
instead of 6 h, cell attachment was observed after 30 min of
exposure to the surface of the 24-well plate. These data show
that after only 30 min there are almost 2.5-fold more bifA
cells (250 cells per field of view) than WT cells (100 cells
per field of view) attached to the surface (Fig. 1C). These
results confirm that bifA mutant surface-attached cells out-
number WT cells. Inspection of these images and of planktonic
cultures revealed no obvious difference in cell clustering of the
bifA mutant cells relative to the WT (data not shown), indi-
cating that the increase in bifA cell number occurs primarily
via an increase in cell-to-surface interactions rather than cell-
cell aggregation in the planktonic phase.
The initial attachment phase of biofilm formation has been
described as occurring in two steps (8, 20). The first step,
whereby cells attach to the surface by a single cell pole, is
called reversible attachment. Cells at this step can easily detach
from the surface and return to the planktonic phase. The
second step, which occurs when reversibly attached cells be-
come attached via the long axis of the cell, is designated irre-
versible attachment. Such irreversibly attached cells appear to
interact more firmly with the surface. Because bifA mutant
cells show increased surface attachment at an early stage in
biofilm formation, it seemed plausible that the bifA mutant
might also be altered in its ability to transition from reversible
to irreversible attachment.
The reversible-to-irreversible transition was monitored by
time-lapse microscopy after a 5-min encounter of cells with the
surface. The sadB mutant was included as a control since this
mutant has been shown to be defective at this step in biofilm
formation (8). The results of this analysis (Fig. 1D) show that
the bifA mutant does not differ in the percentage of reversibly
attached cells (40%) relative to the WT (37%), whereas
the sadB mutant exhibits a much higher percentage of revers-
ibly attached cells (89%), a finding for sadB that is consistent
with previously published results (8). Thus, the increase in
bifA mutant cell attachment is likely not due to an increased
transition from reversible to irreversible attachment.
The pel-derived polysaccharide is required for hyperbiofilm
formation by the bifA mutant. Given that the original
bifA::Tn mutant was isolated, in part, due to its increased CR
binding relative to the WT, we hypothesized that bifA mutants
produce an increased level of polysaccharide that directly im-
pacts biofilm formation. In P. aeruginosa PA14, it has been
shown that the primary polysaccharide component of biofilm
matirix is synthesized by the pel locus and that this is the
cellular component bound by CR (15, 16). Thus, we tested
whether the pel locus was required for the enhanced CR bind-
ing observed in the bifA mutant by introducing a pelA muta-
tion into the bifA genetic background. The results show that
the pelA mutation completely eliminates both the CR binding
and the wrinkled phenotype of the bifA mutant (Fig. 2A).
Furthermore, the bifA pelA double mutant forms a biofilm
that is nearly identical to that of the pelA single mutant after
24 h (Fig. 2B), indicating that increased pel-derived polysac-
charide production in the bifA mutant is required for the
hyperbiofilm formation observed.
We tested whether the overproduction of polysaccharide in
the bifA mutant was due to an increase in transcription of the
pel locus. However, no statistically significant difference (P 
0.25) in pelA or pelG transcript levels was observed between
the WT and the bifA mutant when grown on an agar plate
(Fig. 2C) or as a static planktonic culture (data not shown).
These data suggest that increased pel EPS production in the
bifA mutant is controlled via a mechanism other than tran-
scriptional control.
FIG. 1. Biofilm phenotypes of bifA mutants. (A) Quantification of
biofilms formed by the WT, the bifA::Tn mutant and the bifA mutant
in the 96-well microtiter dish assay. Also shown are the single-copy
complemented strains of the WT and the bifA mutant carrying an
insertion of either the Tn7 element alone (WT::Tn7 and bifA::Tn7)
or the Tn7 harboring a His-tagged version of bifA (WT::Tn7-His-bifA
and bifA::Tn7-His-bifA). Cells were grown in M63 with glucose,
MgSO4, and CAA for 6 h at 37°C prior to crystal violet staining. Crystal
violet was solubilized in 30% glacial acetic acid and measured at
OD550. (B) ALI assay. Top-down phase-contrast images of the WT and
the bifA mutant either alone or carrying insertions of the Tn7 (Tn7
vector) or the Tn7 with His-tagged bifA (Tn7-His-bifA) are shown.
Cells were grown in a 24-well plate for 6 h at 37°C, and images were
recorded at a magnification of 1,400. (C) Quantification of initial
attachment of the WT and the bifA mutant. Cells were incubated at
37°C for 30 min. Images were recorded at a magnification of 1,400
over eight fields of view for each strain. The graph indicates the
average number of cells attached to the substratum (n  8) for each
strain. (D) Quantification of reversible attachment of the WT, the
sadB mutant and the bifA mutant. Strains were incubated in 24-well
plates for 5 min at 37°C. Time-lapse images were captured in 1-min
intervals and converted to QuickTime movies for analysis. Irreversibly
attached cells were scored as cells that did not move during the 1-min
interval and were attached by the long axis of the cell. Reversibly
attached cells were those that moved during the interval and were
attached by a cell pole.
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Increased pel-synthesized polysaccharide is not responsible
for the defect in swarming motility observed in the bifA
mutant. As indicated by the initial identification of the bifA::Tn
mutant and confirmed in the bifA deletion mutant, bifA mu-
tants fail to swarm compared to the WT (Fig. 3). Given that P.
aeruginosa PA14 swarming motility requires a functional fla-
gellum and the production of rhamnolipids as a surface-wet-
ting agent (26, 53), we tested whether bifA mutants synthesize
a functional flagellum and produce rhamnolipids. In swimming
assays, the bifA mutants swim nearly as well as the WT (swim
zone measurements: bifA  22.9  1.7 mm; bifA::Tn  23 
1.6 mm; WT  29  2 mm), indicating that bifA mutants make
a functional flagellum. The bifA mutants also produce rham-
nolipids at a level similar to that for the WT (data not shown).
We also determined whether bifA mutants were capable of
type IV pilus-mediated twitching motility, a form of surface
motility that has also been shown to be important for P. aerugi-
nosa biofilm formation (37), and found that the bifA mutants
twitch as well as the WT (twitch zone measurements: bifA 
12.7  1.6 mm; bifA::Tn  12.2  1.6 mm; WT  13.5  2.1
mm).
On swarm plates, however, bifA mutants do not radiate
outward from the point of inoculation but instead resemble the
flgK mutant, a control strain that does not make a functional
flagellum (Fig. 3B). The bifA mutant forms a colony with the
wrinkled morphology on the swarm plate similar to what was
observed in the CR plate assays. This wrinkled phenotype,
indicating overproduction of polysaccharide, prompted us to
test whether enhanced polysaccharide production interferes
with the ability of the bifA mutant to swarm. Support for this
notion comes from recent studies indicating that pelA mutants
exhibit enhanced swarming relative to the WT, as reported by
Caiazza et al. (7) and as shown in the present study (Fig. 3).
When tested on swarm plates, the bifA pelA double mutant
also shows no radiation of swarm tendrils out from the point of
inoculation. Measurement of the swarm zone diameter shows
there is no statistically significant difference between the bifA
pelA double mutant and the single bifA mutant (Fig. 3B). As
expected, however, the bifA pelA mutant colony was no
longer wrinkled due to the elimination of pel-mediated poly-
saccharide production. Thus, mutation of pelA in the bifA
mutant strain and subsequent loss of excess polysaccharide
synthesis does not restore swarming motility in the bifA mu-
tant, indicating that overproduction of polysaccharide is not
sufficient to inhibit swarming motility by the bifA mutant.
The GGDQF and EAL domains of BifA are both required
for complementation of the bifA mutant. The bifA gene en-
codes a protein of 688 amino acids with a predicted MW of
78 kDa. The two notable domains found in the BifA protein
are a GGDEF-like domain and an EAL domain. GGDEF
domains have been shown to be important for the activity of
DGCs, which catalyze the synthesis of one molecule of c-di-
GMP from two GTP molecules (40). The GGDEF-like domain
of BifA maintains all but one of the conserved signature amino
acid residues with the sequence GGDQF. EAL motifs, on the
other hand, are required for the activity of c-di-GMP-degrad-
ing PDEs (11, 47), with the glutamic acid (E) residue previ-
ously shown to be critical for PDE activity in other systems (5,
52). The signature E, A, and L residues of this motif are
conserved in BifA.
To test the importance of these motifs in the function of
BifA, we generated mutations converting the key residues of
each domain to alanine residues. We then assessed the abil-
ity of the WT His-BifA, His-BifA-AAAAA (GGDQF to
FIG. 2. pelA is required for the enhanced CR binding and hyper-
biofilm phenotypes of the bifA mutant. (A) Representative images of
CR binding. Shown are the WT::Tn7, the bifA::Tn7 mutant, the
complemented strains WT::Tn7-His-bifA and bifA::Tn7-His-bifA,
the pelA mutant, and the bifA pelA double mutant. Plates were
incubated for 24 h at 37°C, followed by 48 h at room temperature.
(B) Quantification of CV-stained biofilms. Strains were grown in M63
with glucose, MgSO4 and CAA for 24 h prior to CV staining. (C) qRT-
PCR analysis of pelA and pelG expression in agar-grown colonies of the
WT and the bifA mutant. Expression is plotted as picograms of input
cDNA for each strain.
FIG. 3. The pel-derived polysaccharide does not contribute to the
swarming defects of the bifA mutant. (A) Representative images of
the WT, the bifA mutant, the bifA pelA double mutant, and the pelA
mutant swarms after 16 h at 37°C. (B) Graph showing the average
diameter (in millimeters) of swarms from triplicate platings for each
strain.
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AAAAA), and His-BifA-AAL (EAL to AAL) proteins, ex-
pressed from the multicopy pMQ80 plasmid, to complement
the bifA mutant in the 96-well plate assay. The results show
that expression of His-tagged BifA protein from this plasmid in
the bifA mutant leads to a reduction in biofilm formation to
approximately WT levels (Fig. 4A), a finding consistent with
our observations in the single copy complementation experi-
ments (see Fig. 1A). In contrast, expression of either His-BifA-
AAAAA or His-BifA-AAL fails to suppress the hyperbiofilm
phenotype of the bifA mutant. Using Western blotting to
detect His-BifA in these strains, we confirmed that the His-
BifA-AAAAA and His-BifA-AAL mutant proteins are stable
and expressed at levels similar to that for WT BifA (Fig. 4B).
These results indicate that both the EAL domain and the
GGDQF domain of BifA are required for proper function
in vivo.
In the experiments described above, we utilized the multi-
copy pMQ80 vector for arabinose-inducible expression of His-
BifA proteins in order to facilitate an assessment of protein
levels and stability via Western blot analysis. It should be noted
that we were unable to detect His-BifA when expressed in
single copy, although this construct could complement a bifA
mutant. Although we could not assay protein levels of the
single copy mutant constructs, we did observe that the His-
BifA-AAAAA and His-BifA-AAL mutant proteins in single
copy fail to complement the bifA mutant (data not shown) in
the same manner observed for the multicopy complementation
experiments described above.
BifA localizes to the inner membrane. Using the protein
structure prediction algorithms TMHMM2 and Tmpred, the
BifA protein is predicted to contain a N-terminal transmem-
brane domain, suggesting localization of BifA to the inner
membrane, with the remaining C-terminal portion containing
the GGDQF and EAL domains residing in the cytoplasm. To
determine the subcellular localization of BifA, we performed
cellular fractionations using a Sarkosyl extraction procedure to
separate the inner and outer membranes (34), followed by
Western blotting of these fractions to detect His-BifA. The
results reveal that His-BifA is indeed highly enriched in the
inner-membrane fraction (Fig. 4C). His-BifA could be weakly
detected in whole-cell extracts and was enriched in the TM
fraction and the inner-membrane fraction but was not detected
in the outer-membrane fraction. The His-BifA-AAAAA and
His-BifA-AAL mutant proteins are also enriched in the inner-
membrane fraction, indicating that the GGDEF and EAL do-
mains are not required for proper cellular localization (data
not shown). Whether inner-membrane localization is required
for the function of BifA is not yet clear. Deletion of the N-
terminal region of BifA, including the predicted transmem-
brane (TRM) domain, leads to a loss of protein stability rela-
tive to the WT protein, making it difficult to draw any firm
conclusions regarding the function of the BifA TRM protein.
FIG. 4. Assessment of function, stability, and cellular localization of BifA. (A) Assessment of the ability of the bifA gene, the bifA-AAAAA
(GGDEF3AAAAA) mutant, and the bifA-AAL (EAL3AAL) mutant to complement the bifA mutant when provided on an arabinose-inducible
plasmid (pMQ80). The graph shows the quantification of biofilm formed by the WT and the bifA mutant carrying either the pMQ80 vector alone
or pMQ80 containing the His-tagged bifA gene (p-his-bifA). Also shown is the quantification of biofilm formed by the bifA mutant carrying
pMQ80 with the bifA-AAAAA mutant (p-his-bifA-AAAAA) or the bifA-AAL mutant (p-his-bifA-AAL). Cells were grown for 6 h in the presence
of 0.5% arabinose prior to CV staining. (B) Evaluation of expression and stability of WT BifA, BifA-AAAAA, and BifA-AAL proteins expressed
from the pMQ80 constructs in panel A. Western blot showing the level of BifA expressed under the same conditions used in the biofilm assays
in panel A. Equal amounts of cells were lysed and separated by SDS-PAGE. BifA was detected by using an anti-penta-His antibody. Purified
His-BifA served as a control. (C) Cellular localization of BifA. Cellular fractions of the bifA mutant carrying either vector alone (pMQ80) or
vector containing the bifA gene (p-his-bifA) were generated as described previously (see Materials and Methods). Approximately 1 g of total
protein from each fraction was separated by SDS-PAGE. Fractions are indicated as whole-cell (WC), soluble cytoplasmic (Cyt), total membrane
(TM), inner-membrane (IM), and outer-membrane (OM) fractions. Western analysis was performed with either an anti-penta-His antibody, an
anti-SecY antibody, or an anti-OprF antibody. The arrow indicates the BifA band. Purified His-BifA served as a control. SecY (50 kDa) served
as a control for inner- membrane localization and OprF (35 kDa) served as an outer-membrane marker.
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However, when expressed in single copy, BifA TRM shows
partial complementation of the bifA mutant biofilm defect,
suggesting that the N-terminal region (and hence, membrane
localization) is not absolutely required for BifA function in
vivo (data not shown).
Western blotting with antibodies to SecY, an inner-mem-
brane protein (1), and OprF, an outer-membrane-localized
protein (3, 18), confirms that the inner and outer membranes
were successfully fractionated.
BifA demonstrates PDE activity in vitro. The complemen-
tation data described above indicate that the GGDQF and
EAL domains of BifA are both important for its function (Fig.
4A). Thus, we set out to purify the WT His-BifA, His-BifA-
AAAAA, and His-BifA-AAL proteins to test for both PDE
and DGC activity. However, during the purification procedure,
we found that His-BifA-AAAAA and His-BifA-AAL mutant
proteins were stable in crude extracts (Fig. 5A) but that sub-
sequent purification steps led to accelerated degradation of the
mutant proteins relative to WT BifA. Therefore, we evaluated
the activity of the WT His-BifA and the His-BifA mutant
proteins in crude extracts compared to extracts prepared from
the vector control strain.
We first assessed PDE activity in crude extracts by using a
colorimetric assay involving PDE-mediated cleavage of the
synthetic substrate, bis-pNPP (5). The data show that bis-pNPP
is cleaved in crude extract containing the WT His-BifA protein
and cleavage occurs in a concentration-dependent manner
(Fig. 5B). Furthermore, the PDE activity observed in WT
extracts is significantly higher at all concentrations shown than
that of the vector control extract. In contrast, the activity in
crude extract containing either the His-BifA-AAL or His-
BifA-AAAAA mutant protein does not differ significantly
from the control extract at any of the concentrations shown.
These results suggest that mutational inactivation of either the
GGDQF or EAL domain abolishes BifA PDE activity.
Next, we assessed the PDE activity in crude extracts using
the native substrate, c-di-GMP. In WT extracts, the levels of
c-di-GMP are reduced in a dose-dependent fashion compared
to the input levels of c-di-GMP shown in the no-protein con-
trol, indicating the presence of c-di-GMP cleavage activity
(Fig. 5C). CC3396, the purified protein serving as a positive
control for PDE activity, cleaves c-di-GMP to form the linear
product, pGpG. For the WT extracts, we observe the disap-
pearance of c-di-GMP but do not see the accumulation of
pGpG. This absence of pGpG product is likely due to subse-
quent cleavage and/or degradation of pGpG either by BifA
itself or some other activity present in the extract. In fact,
addition of crude extract prepared from the strain carrying the
vector control to the CC3396 reaction leads to disappearance
of the pGpG product (data not shown), indicating that degra-
dation of pGpG occurs via a BifA-independent activity present
in crude extracts.
In contrast to the WT extracts, crude extracts containing
either His-BifA-AAAAA or His-BifA-AAL show no detect-
FIG. 5. Analysis of PDE activity of BifA in vitro. (A) Western blot showing the levels of WT His-BifA, His-BifA-AAL, and His-BifA-AAAAA
protein in crude extracts of E. coli cells carrying either pQE-30 with the bifA gene, the bifA-AAL mutant, or the bifA-AAAAA mutant. Crude
extracts were prepared as described previously (see Materials and Methods). Equal quantities (3 g) of total protein were separated by SDS-PAGE
and detected by Western blotting with an anti-penta-His antibody. (B) Assessment of PDE activity in the crude extracts (described above)
compared to control extract (prepared from E. coli carrying the pQE-30 vector only) using the substrate bis-pNPP. The graph shows the
dose-response curve generated by twofold serial dilutions of crude extract incubated in the presence of bis-pNPP for 20 min. The release of
p-nitrophenol was quantified at OD410. The asterisk indicates statistical significance (P  0.05). (C) Detection of PDE activity in crude extracts
using the radiolabeled substrate, c-di-GMP. Crude extracts containing either WT BifA, BifA-AAL, and BifA-AAAAA mutant proteins in
increasing concentrations (3 or 9 g of protein per reaction) were incubated with c-di-GMP. A no-protein (NP) control lane indicates the amount
of input substrate. CC3396 served as a positive control for PDE activity, converting c-di-GMP to the linear form, pGpG. (D) Purification of
His-tagged BifA. His-tagged BifA was purified from crude extracts using a His-Trapp-FF NiSO4 column. The purity of BifA was evaluated by
SDS-PAGE separation and Coomassie blue staining (lane 3) compared to crude extract (CE). The sizes of markers (M) in lane 1 are indicated
in kilodaltons. (E) PDE activity of purified His-BifA. The graph shows a dose-response curve generated by twofold serial dilutions of BifA assayed
as described in panel B.
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able reduction in c-di-GMP levels. The presence of the mutant
proteins in these extracts at levels equivalent to the WT protein
was confirmed by Western blotting (results not shown). These
results confirm our observations in the colorimetric assay de-
scribed above. Taken together, the data indicate that the WT
BifA protein is able to cleave c-di-GMP and that cleavage
requires both the GGDQF and the EAL domains of BifA.
In order to further confirm that the WT BifA protein has
PDE activity, we continued with the purification of WT His-
BifA from crude extracts using a nickel affinity resin (Fig. 5D)
and tested its ability to cleave bis-pNPP in the colorimetric
assay described above. As expected based on results with WT
crude extracts, purified His-BifA also exhibits PDE activity in
a concentration-dependent manner (Fig. 5E).
Given that BifA has a GGDEF-like motif with the sequence
GGDQF, we also tested whether BifA possesses a DGC activ-
ity using established protocols (40). However, we could not
detect synthesis of c-di-GMP using either purified His-BifA or
crude extracts containing WT His-BifA, despite our ability in
control experiments to synthesize c-di-GMP using purified
PleD, a well-characterized DGC protein with known c-di-GMP
cyclase activity (data not shown) (40). These data indicate that
BifA either does not possess DGC activity or that such activity
is below our level of detection.
The bifA mutant exhibits increased cellular levels of c-di-
GMP relative to WT. Given that BifA possesses the ability to
cleave c-di-GMP in vitro, we predicted that disruption of BifA
activity might impact the cellular pools of c-di-GMP in vivo.
Thus, we examined levels of c-di-GMP in bifA mutant and
WT cells when grown in the presence of radiolabeled inorganic
phosphate and further analyzed as previously described (19,
33). Inspection of the two-dimensional TLC plate autoradio-
graphs indicates that there is an increase in the levels of the
c-di-GMP component in bifA mutant cells relative to WT
cells (Fig. 6A). Quantification of c-di-GMP and normalization
to total 32Pi incorporation (for which there was no significant
difference between the two strains [P  0.42]) show that the
bifA mutant accumulates 2.5-fold more c-di-GMP than
does the WT (Fig. 6B). This result is consistent with our in
vitro observations and lends further support for the role of
BifA as a c-di-GMP PDE.
Genetic interactions between bifA and sadB in biofilm for-
mation, pel-mediated polysaccharide synthesis, and swarming
motility. Recent findings from our laboratory have established
the sadB gene as playing a key role in the inverse regulation of
biofilm formation and swarming by P. aeruginosa (7). These
studies show that sadB mutants are unable to form a biofilm
but exhibit an enhanced ability to swarm. Thus, the sadB gene
product promotes biofilm formation while simultaneously in-
hibiting swarming motility. This inverse regulation of surface
behaviors mirrors the inverse regulation of motility and sessil-
ity by intracellular levels of c-di-GMP as has been shown in
other systems (reviewed in reference 42). Given that the stud-
ies presented here establish a role for the bifA gene as a
regulator of c-di-GMP levels, we wondered whether the sadB
gene might function downstream of the bifA gene in response
to c-di-GMP signaling in a pathway that inversely regulates
biofilm formation and swarming motility in P. aeruginosa.
To determine the epistatic relationship between the sadB
and bifA genes, we constructed a deletion of the bifA gene in
the sadB mutant background. We then tested the resulting
bifA sadB double mutant for biofilm formation in the 96-well
plate assay. In these assays, the biofilm formed by the bifA
sadB mutant is severely deficient relative to the WT and is
nearly indistinguishable from the sadB single mutant (Fig. 7A).
These results indicate that the sadB gene is required for the
hyperbiofilm formed by the bifA mutant and support a ge-
FIG. 6. The bifA gene influences c-di-GMP levels in vivo. (A) Au-
toradiographs of representative two-dimensional TLC plates used to
separate [32P]orthophosphate-labeled, acid-extracted whole-cell ex-
tracts prepared from both the WT and the bifA mutant. The circle
indicates the position of c-di-GMP. (B) Quantification of c-di-GMP
levels. Autoradiographs were analyzed using the Storm 860 and Im-
ageQuant software (v5.1). The percentage of label incorporated into
c-di-GMP was normalized to total 32P labeling and expressed as the
percentage of c-di-GMP. The asterisk indicates statistical significance
(P  0.02).
FIG. 7. Genetic interactions between bifA and sadB in relation to
biofilm formation, EPS production, and swarming. (A) Quantification
of CV-stained biofilm formed by the WT, the bifA mutant, the sadB
mutant, and the bifA sadB double mutant. Cells were grown for 8 h
prior to CV staining. (B) CR binding by the indicated strains. Plates
were incubated for 24 h at 37°C, followed by 48 h at room temperature.
(C) Diameter (in millimeters) of swarm zones plotted for each of the
indicated strains. Swarm plates were incubated for 16 h at 37°C.
(D) Swim reversal frequencies of the indicated strains under high-
viscosity (15% Ficoll) conditions are plotted. Approximately 135 total
cells were counted per strain to determine the reversal frequency,
expressed as the number of reversals per cell. The asterisks indicate
statistical significance (P  0.0005).
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netic pathway in which the sadB gene functions downstream of
the bifA gene in regulating biofilm formation.
The recent report by Caiazza et al. also shows that sadB
mutants are deficient in CR binding and produce colonies with
a smooth morphology due to defects in the production of the
pel-derived polysaccharide (7). In contrast, bifA mutants ex-
hibit hyper-CR binding and a highly wrinkled colony morphol-
ogy due to increased production of pel polysaccharide (see Fig.
2A and 7B). To determine whether the bifA gene regulates
polysaccharide production via SadB, we tested the CR-binding
ability of the bifA sadB mutant and found that CR binding is
considerably reduced relative to the bifA mutant, but CR
binding is not eliminated, as is the case for the sadB mutant
alone. Furthermore, the colony morphology of the bifA sadB
mutant is far less wrinkled than is the bifA single mutant.
These findings indicate that SadB contributes to increased pel
polysaccharide production in the bifA mutant. Taken to-
gether with the biofilm results described above, these data
further support the notion that sadB functions downstream of
bifA in regulating biofilm formation and that sadB does so by
influencing pel-mediated polysaccharide synthesis.
The epistasis studies with the bifA and pelA genes described
earlier indicated that the accumulation of polysaccharide in the
bifA mutant does not directly inhibit the swarming motility of
the bifA mutant (see Fig. 3A). Thus, some other factor(s)
must be responsible for the swarming defect in the bifA
mutant. Given that sadB mutants are hyperswarmers and that
overexpression of the sadB gene can repress the swarming
motility of the WT strain (7), it seemed plausible that inhibi-
tion of the swarming motility in the bifA mutant could be
dependent on SadB. When tested on swarm agar plates, the
bifA sadB mutant is indeed a hyperswarmer relative to the
WT, with a swarming zone comparable to that observed for
the sadB mutant alone (Fig. 7C). This result indicates that
SadB is required to inhibit the swarming motility of the bifA
mutant. The data also provide evidence that sadB is influenced
by the bifA gene (and likely c-di-GMP signaling) in its role as
a regulator of both biofilm formation and swarming motility.
Caiazza et al. also provided evidence that SadB controls
swarming motility by modulating the rate of flagellar reversals
(7). More specifically, they reported that sadB mutants show a
higher rate of flagellar reversals in high viscosity medium (15%
Ficoll), conditions that have previously been equated to con-
ditions encountered while swarming (53). Because the bifA
mutant is inhibited for swarming motility, the opposite pheno-
type to that of the sadB mutant, we predicted that the bifA
mutant would show a reduced rate of flagellar reversals rela-
tive to the WT. To test this prediction, we monitored the
swimming behavior of the bifA mutant in 15% Ficoll and
measured the frequency of swim reversals. Consistent with our
hypothesis, the bifA mutant shows a statistically significant
2-fold decrease in reversals compared to the WT. As a con-
trol, the sadB mutant showed the expected increase in rever-
sals.
DISCUSSION
We present biochemical evidence that BifA, a dual EAL/
GGDEF domain-containing protein, possesses PDE activity
and is capable of cleaving both the synthetic substrate, bis-
pNPP, and the native substrate, c-di-GMP, in in vitro cleavage
assays. Mutation of the glutamic acid (E) residue of the core
EAL motif shown to be critical for PDE function in other
systems (5, 52) renders BifA nonfunctional in PDE activity
assays. This mutation also abolishes the ability of BifA to
complement any of the phenotypes associated with the bifA
mutant. A role for BifA as a PDE is further supported by our
observations that the bifA mutant has 2.5-fold-higher intra-
cellular levels of c-di-GMP than does the WT in whole-cell
labeling experiments.
Despite the presence of a GGDEF domain, BifA does not
appear to possess DGC activity required for the synthesis of
c-di-GMP. However, this is not entirely unexpected given that
other dual EAL/GGDEF domain-containing proteins possess
only PDE activity (11, 25, 33) and that the GGDEF-like do-
main of BifA differs from the consensus sequence in the core
motif, with the sequence GGDQF. Recent data from Cau-
lobacter cresentus indicates that the GGDEF domain of the
PDE CC3396, which also differs from the consensus of the core
motif with the sequence GEDEF, appears to act as a positive
allosteric effector site for GTP (11). Consistent with a role for
the BifA GGDQF domain in stimulating PDE activity, we
observe that replacement of the GGDQF core residues with
alanine residues greatly diminishes the PDE activity of BifA.
Experiments to further address the role of this domain as an
allosteric effector site are currently under way.
Mutating the bifA gene results in an increased pool of c-di-
GMP and impacts both biofilm formation and swarming mo-
tility. How is this increased pool of c-di-GMP linked to the
alterations in biofilm formation and swarming motility?
In the case of biofilm formation, mutating bifA results in
increased production of the Pel polysaccharide, as indicated by
increased binding of CR that is dependent on pelA. Like the
pelA mutant, the bifA pelA double mutant is biofilm defective,
indicating that a functional pel locus is required for the in-
creased biofilm formation observed in the bifA mutant. Ac-
cording to our microscopy studies, enhanced biofilm formation
by the bifA mutant is triggered as early as the initial attach-
ment phase, indicating that enhanced EPS production pro-
motes initial attachment, a result consistent with recent find-
ings from other groups (29, 54). Given that c-di-GMP is an
allosteric activator of cellulose synthesis in Acetobacter xylinum
(43), the increase in Pel polysaccharide could be due to the
role of c-di-GMP as a positive allosteric effector of polysac-
charide production, a result consistent with our observation
that increased binding of CR is not correlated with increased
expression of the pelA or pelG genes. However, no such allo-
steric regulatory role for c-di-GMP has yet been documented
for Pel polysaccharide production in P. aeruginosa.
In addition to its hyperbiofilm phenotype, the bifA mutant
is completely defective for swarming and displays a wrinkled
colony phenotype associated with EPS production when grown
on swarming motility agar. Based on the observation that mu-
tating the pel locus of the WT strain results in increased swarm-
ing motility, we predicted that the overproduction of the Pel
polysaccharide might inhibit swarming motility. To our sur-
prise, while mutating pelA in the bifA mutant background
eliminated the wrinkled colony phenotype, swarming motility
was not restored. These data indicate that the defect in swarm-
ing due to the bifA mutant was not due to excess polysaccha-
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ride production. As shown by genetic studies presented in the
companion manuscript by Merritt et al., the accumulation of
c-di-GMP mediated by SadC is required for loss of swarming in
the bifA mutant (32).
What then was causing the swarming defect in the bifA
mutant? We recently showed that mutating the sadB gene
impacts flagellar function by modulating the rate of flagellar
reversals specifically under high-viscosity conditions, an envi-
ronment analogous to that encountered by cells while swarm-
ing (7). That is, the increased flagellar reversal rates of the
sadB mutant were correlated with a hyperswarming phenotype.
Given the swarm defect of the bifA mutant, we predicted that
this strain would show decreased flagellar reversals compared
to the WT. Indeed, in the present study we showed the bifA
mutant has a decreased rate of flagellar reversals compared to
the WT under high-viscosity conditions. Our data extend the
correlation we observed previously between rates of flagellar
reversals and the robustness of swarming motility.
Taken together with our recently published work (7, 32),
phenotypic studies indicate that SadC, BifA, and SadB are all
involved in the inverse regulation of biofilm formation and
swarming motility. Mutations in the sadC and sadB genes re-
sult in strains defective for biofilm formation and a hyper-
swarming phenotype. In contrast, mutating bifA renders the
strain a hyperbiofilm former and completely blocked for swarm-
ing motility. The similarity in phenotypes among these mutants
suggested that they might function in the same genetic pathway,
and our epistasis data published here and elsewhere (32) support
this hypothesis.
Epistasis analysis presented in the companion study by Mer-
ritt et al. (32) indicates that BifA and SadC function in the
same pathway in the inverse regulation of biofilm formation
and swarming motility. Mutating sadC in the bifA mutant
background results in a significant reduction, but not elimina-
tion, of the hyperbiofilm and hyper-CR binding of the bifA
mutant and a partial restoration of swarming motility. These
data indicate that at least one other DGC synthesizes c-di-
GMP under the growth conditions used in our study (32).
The data presented above suggest that multiple DGCs gen-
erate c-di-GMP that is degraded by BifA, but BifA might be
required to modulate c-di-GMP under a broad range of envi-
ronmental conditions. Consistent with this hypothesis, the
bifA mutant is a hyperbiofilm former relative to the WT when
tested for biofilm formation on at least 40 different carbon and
energy sources, including when cells are grown on glucose,
arginine, citrate, or LB (S. L. Kuchma and G. A. O’Toole,
unpublished data). We also showed that the increased biofilm
formation and the block in swarming motility observed for the
bifA mutant are dependent on the previously described sadB
locus (7, 8). Similarly, the boost in biofilm formation and CR
binding observed in strains carrying multiple copies of the sadC
gene is largely eliminated when the sadB gene is mutated (32).
Taken together, these genetic data suggest that SadC and BifA
function upstream of SadB.
Previous studies of SadB led to the identification of a genetic
pathway, including the chemotaxis-like CheIV locus, in the
inverse regulation of biofilm formation and swarming motility
(7). The identification and characterization of SadC by Merritt
et al. (32), and of BifA, presented here, have expanded the
SadB genetic pathway to include components that function
upstream of SadB in regulating surface behaviors of P. aerugi-
nosa. Furthermore, the characterization of SadC and BifA as
contributing to c-di-GMP metabolism implicates this signaling
molecule in the regulation of these surface behaviors. Based on
these data, we propose that SadC and BifA function together
to modulate the levels of c-di-GMP in the cell and that the
resulting levels of this molecule impact both EPS production
and flagellar function and thus biofilm formation and swarm-
ing motility. However, we cannot completely rule out the pos-
sibility that these genes function in similar but parallel path-
ways. For example, given that a sadB mutation does not
eliminate CR binding by the bifA mutant, it is plausible that
BifA and SadB both contribute to Pel polysaccharide synthesis
via distinct pathways. Alternatively, we would argue that c-di-
GMP levels primarily influence Pel polysaccharide synthesis
through a SadB-dependent pathway but that in a bifA mutant
the levels of c-di-GMP are sufficiently elevated to stimulate Pel
activity via additional SadB-independent mechanisms.
Given that there are 40 proteins predicted to be involved
in c-di-GMP metabolism in P. aeruginosa, a central question in
the field now focuses on how this bacterium coordinates the
activities of these proteins to effectively control cellular levels
of c-di-GMP. We are interested in pursuing this question by
exploring how SadC and BifA specifically impact surface be-
haviors under the conditions studied here. There are a number
of mechanisms that might allow for coregulation of SadC and
BifA. For example, the sadC and bifA genes might be cotrans-
criptionally regulated. However, based on a survey of pub-
lished microarray studies, we find no evidence that the sadC
and bifA genes are differentially expressed under conditions
that impact biofilm formation (2, 35, 46, 56). Another mecha-
nism to coordinate DGC and PDE activities may involve their
spatial restriction within the cell. Recent work by Paul et al.
illustrates the importance of cellular localization in the proper
function of the PleD DGC (40). Together with Merritt et al.,
we have shown that both BifA and SadC localize to the cyto-
plasmic membrane. Colocalization of BifA and SadC to the
same membrane hints at the potential for interaction between
these proteins and may provide a mechanism for coregulation
of their enzymatic activities. Finally, given that cellular GTP
levels may reflect the energy status of the cell and the pool of
substrate for DGC enzymes, allosteric regulation of BifA by
GTP may provide an additional level of regulation for this
system.
A more complete understanding of the role of SadC, BifA,
and SadB, as well as the downstream chemotaxis-like compo-
nents, should provide additional insight into how P. aeruginosa
controls c-di-GMP-dependent biofilm formation and swarming
motility as this microbe transitions from a planktonic to a
surface-associated lifestyle.
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